PRL and myeloid sarcoma: Thisdiscrepancy might be explained by the fact that the participants in our MS group hadgreater disability (as assessed with the EDSS) and a relatively short diseaseduration, because some PRLs fade over time and because a PRL is a predictor ofdisability accrual(5,23,24).